Ministry compares private insurers

Israel's insurance supervisor, Yadin Antebi, released the results of the Finance Ministry's comparative study of private insurance plans available in Israel.

By MATTHEW KRIEGER
March 20, 2007 07:07

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

Israel's insurance supervisor, Yadin Antebi, released the results of the Finance Ministry's comparative study of private insurance plans available in Israel. The study was undertaken to assist those who purchase private insurance plans in choosing the right plan. Factors that were considered as part of the study included the policy's coverage of certain surgeries, including transplants - both here and abroad - cost of the policy and average cost of deductibles for out-patient services and purchase of medicines. The Finance Ministry has published the full results of the study on its Web site at www.gov.il/hon/2001/insurance/briut.asp.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS